Stress Management And Resiliency Training for Sexuality


About this study

This study seeks to find out if Sex SMART (Stress Management And Resiliency Training for Sexuality), using mindfulness techniques in a woman's everyday routine, is a feasible and effective treatment to increase sexual function in women who report sexual distress compared to those receiving the current standard of care.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  1. Female
  2. Fluent in English
  3. 18 years of age or older
  4. In a partnered relationship
  5. Willing to attend up to three in-person visits at Mayo Clinic Rochester, MN
  6. Have a willing partner who can attend the treatment interventions with the patient
  7. Meet the following criteria for female Sexual Interest/Arousal Disorder (according to DSM 5)
    1. Endorse at least three of the following:
      1. Absent or reduced interest in engaging in any kind of sexual activities
      2. Absent or reduced sexual or erotic thoughts/fantasies
      3. Absent or reduced initiation of sexual activity OR Absent or reduced willingness to be sexual if your partner initiates
      4. Reduced or absent sexual excitement/pleasure during almost all sexual activities
      5. Reduced or absent sexual response to any erotic cues (written, verbal, visual)
      6. Reduced or absent physical sexual arousal during almost all sexual activities
    2. The above endorsed items cause distress
    3. At least three of the above endorsed items has persisted for 6 months or more

Exclusion Criteria: 

  1. Any woman who reports dyspareunia (painful sex) that is not relieved by the use of a personal lubricant.
  2. Untreated psychiatric disorder
  3. Unstable psychotropic medications (need three months of stability)
  4. Has an unstable psychiatric disorder which is not being treated (need three months of stability)
  5. Is on an unstable dose of antidepressant (need three months of stability)

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Stephanie Faubion, M.D., M.B.A.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer